Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP525355.RAfCTTvlu9fvFTkdKOX3zN-WMUqDTrmn49LTowdTW9J34130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP525355.RAfCTTvlu9fvFTkdKOX3zN-WMUqDTrmn49LTowdTW9J34130_assertion type Assertion NP525355.RAfCTTvlu9fvFTkdKOX3zN-WMUqDTrmn49LTowdTW9J34130_head.
- NP525355.RAfCTTvlu9fvFTkdKOX3zN-WMUqDTrmn49LTowdTW9J34130_assertion wasGeneratedBy ECO_0000203 NP525355.RAfCTTvlu9fvFTkdKOX3zN-WMUqDTrmn49LTowdTW9J34130_provenance.
- NP525355.RAfCTTvlu9fvFTkdKOX3zN-WMUqDTrmn49LTowdTW9J34130_assertion wasDerivedFrom befree-20150227 NP525355.RAfCTTvlu9fvFTkdKOX3zN-WMUqDTrmn49LTowdTW9J34130_provenance.
- NP525355.RAfCTTvlu9fvFTkdKOX3zN-WMUqDTrmn49LTowdTW9J34130_assertion SIO_000772 11896121 NP525355.RAfCTTvlu9fvFTkdKOX3zN-WMUqDTrmn49LTowdTW9J34130_provenance.
- NP525355.RAfCTTvlu9fvFTkdKOX3zN-WMUqDTrmn49LTowdTW9J34130_assertion evidence source_evidence_literature NP525355.RAfCTTvlu9fvFTkdKOX3zN-WMUqDTrmn49LTowdTW9J34130_provenance.
- NP525355.RAfCTTvlu9fvFTkdKOX3zN-WMUqDTrmn49LTowdTW9J34130_assertion description "[Four tyrosine kinase inhibitors that have activity against KIT are currently being used in clinical trials, and one, STI571, has recently been approved by the United States Food and Drug Administration for treating patients with chronic myelogenous leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP525355.RAfCTTvlu9fvFTkdKOX3zN-WMUqDTrmn49LTowdTW9J34130_provenance.